Financhill
Sell
6

GRDN Quote, Financials, Valuation and Earnings

Last price:
$20.23
Seasonality move :
--
Day range:
$20.06 - $20.73
52-week range:
$14.16 - $26.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.98x
P/B ratio:
8.17x
Volume:
165.9K
Avg. volume:
300.2K
1-year change:
--
Market cap:
$1.3B
Revenue:
$1.2B
EPS (TTM):
-$1.49

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
GRDN
Guardian Pharmacy Services
$321.2M $0.22 9.84% 23.13% $27.33
BKD
Brookdale Senior Living
$816.9M -$0.14 4.88% -13.75% $7.70
ENSG
Ensign Group
$1.2B $1.49 17.73% 27.21% $165.17
LFST
LifeStance Health Group
$332.9M $0.01 11.21% -95.93% $8.86
PACS
PACS Group
$1.1B $0.42 15.23% 26.13% $35.50
PNTG
Pennant Group
$201.5M $0.24 24.62% 48.61% $33.60
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
GRDN
Guardian Pharmacy Services
$20.16 $27.33 $1.3B -- $0.00 0% 0.98x
BKD
Brookdale Senior Living
$6.95 $7.70 $1.6B -- $0.00 0% 0.50x
ENSG
Ensign Group
$149.46 $165.17 $8.6B 28.25x $0.06 0.16% 1.97x
LFST
LifeStance Health Group
$5.60 $8.86 $2.2B -- $0.00 0% 1.66x
PACS
PACS Group
$10.60 $35.50 $1.6B 20.01x $0.00 0% 0.47x
PNTG
Pennant Group
$27.65 $33.60 $953.1M 36.38x $0.00 0% 1.23x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
GRDN
Guardian Pharmacy Services
-- 0.000 -- 0.77x
BKD
Brookdale Senior Living
96.71% -1.110 294.12% 0.54x
ENSG
Ensign Group
6.99% 0.754 1.99% 1.32x
LFST
LifeStance Health Group
15.94% 1.095 10.67% 1.32x
PACS
PACS Group
46.18% -0.502 10.9% 1.57x
PNTG
Pennant Group
14.74% 0.809 5.93% 1.14x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
GRDN
Guardian Pharmacy Services
$64.3M $13M -56.09% -71.46% 4.03% $11.7M
BKD
Brookdale Senior Living
$223.1M $31.4M -5.66% -86.4% -0.67% -$18.4M
ENSG
Ensign Group
$188.1M $101.4M 16.28% 17.64% 9.26% $29.3M
LFST
LifeStance Health Group
$109.8M $1.6M -2.07% -2.48% 0.48% -$10.3M
PACS
PACS Group
$153.9M $710K -- -- -0.33% -$76.7M
PNTG
Pennant Group
$29.4M $12.7M 8.55% 10.97% 6% -$23.2M

Guardian Pharmacy Services vs. Competitors

  • Which has Higher Returns GRDN or BKD?

    Brookdale Senior Living has a net margin of 2.87% compared to Guardian Pharmacy Services's net margin of -7.98%. Guardian Pharmacy Services's return on equity of -71.46% beat Brookdale Senior Living's return on equity of -86.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services
    19.54% $0.15 $163.2M
    BKD
    Brookdale Senior Living
    27.41% -$0.28 $4.5B
  • What do Analysts Say About GRDN or BKD?

    Guardian Pharmacy Services has a consensus price target of $27.33, signalling upside risk potential of 35.58%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.70 which suggests that it could grow by 10.79%. Given that Guardian Pharmacy Services has higher upside potential than Brookdale Senior Living, analysts believe Guardian Pharmacy Services is more attractive than Brookdale Senior Living.

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services
    2 0 0
    BKD
    Brookdale Senior Living
    2 1 0
  • Is GRDN or BKD More Risky?

    Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 0.813, suggesting its less volatile than the S&P 500 by 18.674%.

  • Which is a Better Dividend Stock GRDN or BKD?

    Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays -40.96% of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or BKD?

    Guardian Pharmacy Services quarterly revenues are $329.3M, which are smaller than Brookdale Senior Living quarterly revenues of $813.9M. Guardian Pharmacy Services's net income of $9.4M is higher than Brookdale Senior Living's net income of -$65M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 0.98x versus 0.50x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services
    0.98x -- $329.3M $9.4M
    BKD
    Brookdale Senior Living
    0.50x -- $813.9M -$65M
  • Which has Higher Returns GRDN or ENSG?

    Ensign Group has a net margin of 2.87% compared to Guardian Pharmacy Services's net margin of 6.84%. Guardian Pharmacy Services's return on equity of -71.46% beat Ensign Group's return on equity of 17.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services
    19.54% $0.15 $163.2M
    ENSG
    Ensign Group
    16.04% $1.37 $2.1B
  • What do Analysts Say About GRDN or ENSG?

    Guardian Pharmacy Services has a consensus price target of $27.33, signalling upside risk potential of 35.58%. On the other hand Ensign Group has an analysts' consensus of $165.17 which suggests that it could grow by 10.51%. Given that Guardian Pharmacy Services has higher upside potential than Ensign Group, analysts believe Guardian Pharmacy Services is more attractive than Ensign Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services
    2 0 0
    ENSG
    Ensign Group
    4 1 0
  • Is GRDN or ENSG More Risky?

    Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ensign Group has a beta of 1.032, suggesting its more volatile than the S&P 500 by 3.167%.

  • Which is a Better Dividend Stock GRDN or ENSG?

    Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ensign Group offers a yield of 0.16% to investors and pays a quarterly dividend of $0.06 per share. Guardian Pharmacy Services pays -40.96% of its earnings as a dividend. Ensign Group pays out 4.59% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios GRDN or ENSG?

    Guardian Pharmacy Services quarterly revenues are $329.3M, which are smaller than Ensign Group quarterly revenues of $1.2B. Guardian Pharmacy Services's net income of $9.4M is lower than Ensign Group's net income of $80.3M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Ensign Group's PE ratio is 28.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 0.98x versus 1.97x for Ensign Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services
    0.98x -- $329.3M $9.4M
    ENSG
    Ensign Group
    1.97x 28.25x $1.2B $80.3M
  • Which has Higher Returns GRDN or LFST?

    LifeStance Health Group has a net margin of 2.87% compared to Guardian Pharmacy Services's net margin of 0.21%. Guardian Pharmacy Services's return on equity of -71.46% beat LifeStance Health Group's return on equity of -2.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services
    19.54% $0.15 $163.2M
    LFST
    LifeStance Health Group
    32.97% -- $1.7B
  • What do Analysts Say About GRDN or LFST?

    Guardian Pharmacy Services has a consensus price target of $27.33, signalling upside risk potential of 35.58%. On the other hand LifeStance Health Group has an analysts' consensus of $8.86 which suggests that it could grow by 58.16%. Given that LifeStance Health Group has higher upside potential than Guardian Pharmacy Services, analysts believe LifeStance Health Group is more attractive than Guardian Pharmacy Services.

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services
    2 0 0
    LFST
    LifeStance Health Group
    5 1 0
  • Is GRDN or LFST More Risky?

    Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or LFST?

    Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays -40.96% of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or LFST?

    Guardian Pharmacy Services quarterly revenues are $329.3M, which are smaller than LifeStance Health Group quarterly revenues of $333M. Guardian Pharmacy Services's net income of $9.4M is higher than LifeStance Health Group's net income of $709K. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 0.98x versus 1.66x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services
    0.98x -- $329.3M $9.4M
    LFST
    LifeStance Health Group
    1.66x -- $333M $709K
  • Which has Higher Returns GRDN or PACS?

    PACS Group has a net margin of 2.87% compared to Guardian Pharmacy Services's net margin of -1.11%. Guardian Pharmacy Services's return on equity of -71.46% beat PACS Group's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services
    19.54% $0.15 $163.2M
    PACS
    PACS Group
    15.67% -$0.07 $1.1B
  • What do Analysts Say About GRDN or PACS?

    Guardian Pharmacy Services has a consensus price target of $27.33, signalling upside risk potential of 35.58%. On the other hand PACS Group has an analysts' consensus of $35.50 which suggests that it could grow by 234.91%. Given that PACS Group has higher upside potential than Guardian Pharmacy Services, analysts believe PACS Group is more attractive than Guardian Pharmacy Services.

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services
    2 0 0
    PACS
    PACS Group
    3 0 0
  • Is GRDN or PACS More Risky?

    Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or PACS?

    Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays -40.96% of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. PACS Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios GRDN or PACS?

    Guardian Pharmacy Services quarterly revenues are $329.3M, which are smaller than PACS Group quarterly revenues of $981.8M. Guardian Pharmacy Services's net income of $9.4M is higher than PACS Group's net income of -$10.9M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 0.98x versus 0.47x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services
    0.98x -- $329.3M $9.4M
    PACS
    PACS Group
    0.47x 20.01x $981.8M -$10.9M
  • Which has Higher Returns GRDN or PNTG?

    Pennant Group has a net margin of 2.87% compared to Guardian Pharmacy Services's net margin of 3.71%. Guardian Pharmacy Services's return on equity of -71.46% beat Pennant Group's return on equity of 10.97%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services
    19.54% $0.15 $163.2M
    PNTG
    Pennant Group
    14% $0.22 $375.5M
  • What do Analysts Say About GRDN or PNTG?

    Guardian Pharmacy Services has a consensus price target of $27.33, signalling upside risk potential of 35.58%. On the other hand Pennant Group has an analysts' consensus of $33.60 which suggests that it could grow by 21.52%. Given that Guardian Pharmacy Services has higher upside potential than Pennant Group, analysts believe Guardian Pharmacy Services is more attractive than Pennant Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services
    2 0 0
    PNTG
    Pennant Group
    2 2 0
  • Is GRDN or PNTG More Risky?

    Guardian Pharmacy Services has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.515, suggesting its more volatile than the S&P 500 by 51.458%.

  • Which is a Better Dividend Stock GRDN or PNTG?

    Guardian Pharmacy Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services pays -40.96% of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or PNTG?

    Guardian Pharmacy Services quarterly revenues are $329.3M, which are larger than Pennant Group quarterly revenues of $209.8M. Guardian Pharmacy Services's net income of $9.4M is higher than Pennant Group's net income of $7.8M. Notably, Guardian Pharmacy Services's price-to-earnings ratio is -- while Pennant Group's PE ratio is 36.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services is 0.98x versus 1.23x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services
    0.98x -- $329.3M $9.4M
    PNTG
    Pennant Group
    1.23x 36.38x $209.8M $7.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet or Amazon the Better Buy?
Is Alphabet or Amazon the Better Buy?

Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
OKLO alert for Jun 12

Oklo [OKLO] is down 5.6% over the past day.

Buy
87
SMR alert for Jun 12

NuScale Power [SMR] is down 2.96% over the past day.

Buy
53
PLAY alert for Jun 12

Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock